Skip to main content
. 2014 Jul 8;29(11):1475–1483. doi: 10.1007/s11606-014-2947-1

Figure 1.

Figure 1

Consort diagram for participants who developed hospitalized or treated PAD (revascularization procedure or hospitalized) during the randomized phase of ALLHAT and were eligible for long-term mortality follow-up. *Wilcoxon test for the equality of survival function probability values are: amlodipine vs. chlorthalidone P = 0.099; lisinopril vs. chlorthalidone P = 0.915.

HHS Vulnerability Disclosure